Evaluating adherence to cardiovascular prevention guidelines
Adherence to Secondary Prevention Guidelines for Cardiovascular Risk
This study looks at how well patients who were hospitalized for heart-related issues follow guidelines to prevent future problems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 410 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Consorci Sanitari de l'Alt Penedès i Garraf Academic / other |
| Locations | 1 site (Sant Pere De Ribes, Barcelona) |
| Trial ID | NCT06450561 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess how well patients hospitalized for cardiovascular events follow established clinical guidelines for preventing further complications. It focuses on individuals admitted to cardiology, neurology, or general surgery departments with specific cardiovascular diagnoses. By analyzing adherence rates, the study seeks to identify gaps in care and improve future prevention strategies.
Who should consider this trial
Good fit: Ideal candidates include patients admitted for various acute coronary syndromes, ischemic strokes, or peripheral artery disease.
Not a fit: Patients with limited life expectancy or those who are unlikely to survive hospitalization may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality of care for patients at risk of cardiovascular complications by ensuring better adherence to prevention guidelines.
How similar studies have performed: Other studies have shown that improving adherence to clinical guidelines can lead to better patient outcomes, indicating that this approach has potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Admitted to the cardiology, neurology, or general surgery departments * With any of the following admission diagnoses: Non-ST-segment elevation acute coronary syndrome (NSTEACS) ST-segment elevation acute coronary syndrome (STEACS) Stable angina Unstable angina Non-ST-segment elevation myocardial infarction (NSTEMI) ST-segment elevation myocardial infarction (STEMI) Atherothrombotic ischemic stroke Lacunar stroke Peripheral artery disease Chronic ischemia of lower limbs Vascular ulcer due to arterial cause Exclusion Criteria: * Patients for whom lipid-lowering treatment is ruled out due to limited life expectancy * Patients likely to die during hospitalization * Patients who died during hospitalization
Where this trial is running
Sant Pere De Ribes, Barcelona
- Consorci Sanitari Alt Penedes i Garraf-Hospital Sant Camil — Sant Pere De Ribes, Barcelona, Spain (Recruiting)
Study contacts
- Principal investigator: Lidia Tikhomirova — Csapg
- Study coordinator: Lidia Tikhomirova
- Email: ltikhomirova@csapg.cat
- Phone: +34 938960025
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.